Astragalus membranaceus polysaccharides (APS) show significant potential in reducing seizure frequency and severity by modulating TLR4/NF-B signaling pathways, reducing neuroinflammation, and preventing hippocampal damage. Clinical trials (e.g., NCT05647473) are investigating these effects. Medical Peer Review Submission: Evaluation of Astragalus in Seizure Control 1. Potential Mechanisms of Action 2. Scientific Evidence (10 Examples/Studies) Note: The request asked for quotes
